ARWR

ARWR R&D to Revenue

73.20%Fiscal year

Period ending:

ARWR FY R&D/Revenue%
ARWR FY R&D/Revenue29323.63%-3141.82%
1997-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

ARWR r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 29 observations from Sep 30, 1997 to Sep 30, 2025.

Arrowhead Pharmaceuticals Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
73.2004%
13,776.8516%
142.1945%
118.6115%
149.2129%
140.4034%
45.3971%
299.1901%
147.2633%
26,181.8143%
12,373.6547%
13,221.7429%
2,999.1894%
3,670.7833%
1,106.8316%
138.2701%
165.1654%
637.6266%
905.252%
1,441.2467%
642.2018%
404.1415%
0%
0%
0%
0%
0%
0%
0%

Compare r&d to revenue

All ARWR financial metrics · ARWR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.